Oracle and Cognizant Aim to Accelerate Study Startup in Trials


Cognizant’s Shared Investigator Platform (SIP) has integrated with Oracle Health Sciences. Cognizant and Oracle have combined the SIP solution and study startup offerings to address site challenges and aim to deliver value in the initialization of studies, collaboration, and management.

“Being able to stay connected, reduce administrative work, and stand-up clinical trials quickly is paramount, especially as the world faces the pandemic and must maneuver around social distancing guidelines,” said Srinivas Shankar, Global Head of Life Sciences, Cognizant. “Since 2016, Cognizant’s Shared Investigator Platform has over 130,000 users across 100 countries. This digital solution, in collaboration with Oracle, is helping bridge digital technology and life sciences.”

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.